摘要:
The invention relates to compounds of general formula wherein R1, R2, R3/R3′, R4/R4′ and R5/R5′ are as defined in the specification and to pharmaceutically acceptable acid addition salts, optically pure enantiomers, racemates or diastereomeric mixtures thereof. The compounds are γ-secretase inhibitors which can be useful in the treatment of Alzheimer's disease or common cancers including, but not limited to, cervical carcinomas and breast carcinomas and malignancies of the hematopoietic system.
摘要翻译:本发明涉及通式的化合物,其中R 1,R 2,R 3 / R 3',R 4 / R 4'和R 5 / R 5'如说明书中所定义,以及其药学上可接受的酸加成盐,光学纯对映异构体,外消旋体或非对映体混合物 。 该化合物是γ-分泌酶抑制剂,其可用于治疗阿尔茨海默病或常见癌症,包括但不限于宫颈癌和乳腺癌以及造血系统的恶性肿瘤。
摘要:
The present invention provides compounds of the general formula wherein R4 is one of the following groups and R1, R2, R3, R7, R8, and R9 are as defined in the specification and pharmaceutically acceptable salts, optically pure enantiomers, racemates or diastereomeric mixtures thereof. The compounds are useful for the treatment of Alzheimer's disease.
摘要:
The invention relates to malonamide derivatives of formula wherein each of the variables are as defined herein and to pharmaceutically acceptable acid addition salts, optically pure enantiomers, racemates and diastereomeric mixtures thereof. These compounds are γ-secretase inhibitors and may be used for the treatment of Alzheimer's disease.
摘要:
The invention relates to malonamide derivatives of formula wherein each of the variables are as defined herein and to pharmaceutically acceptable acid addition salts, optically pure enantiomers, racemates and diastereomeric mixtures thereof. These compounds are γ-secretase inhibitors and may be used for the treatment of Alzheimer's disease.
摘要:
The present invention provides compounds of the general formula wherein R4 is one of the following groups and R1, R2, R3, R7, R8, and R9 are as defined in the specification and pharmaceutically acceptable salts, optically pure enantiomers, racemates or diastereomeric mixtures thereof. The compounds are useful for the treatment of Alzheimer's disease.
摘要:
The invention relates to compounds of general formula wherein R1, R2, R3/R3′, R4/R4′ and R5/R5′ are as defined in the specification and to pharmaceutically acceptable acid addition salts, optically pure enantiomers, racemates or diastereomeric mixtures thereof. The compounds are γ-secretase inhibitors which can be useful in the treatment of Alzheimer's disease or common cancers including, but not limited to, cervical carcinomas and breast carcinomas and malignancies of the hematopoietic system.
摘要翻译:本发明涉及通式的化合物,其中R 1,R 2,R 3,R 3,R 3, R 4 / R 4'和R 5 / R 5'如说明书中所定义,并且在药学上 可接受的酸加成盐,旋光纯对映异构体,外消旋物或非对映体混合物。 该化合物是γ-分泌酶抑制剂,其可用于治疗阿尔茨海默病或常见癌症,包括但不限于宫颈癌和乳腺癌以及造血系统的恶性肿瘤。
摘要:
The invention relates to 6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl derivatives of formula I wherein R1, R2 and R3 are as defined herein. The compounds are γ-secretase inhibitors useful in the treatment of Alzheimer's disease or common cancer, including, but not limited to, cervical carcinomas and breast carcinomas and malignancies of the hematopoietic system.
摘要:
The invention relates to 4-oxo-2,3,4,5-tetrahydro-benzo [b][1,4]diazepines of formula I wherein R1, R2, R3 and R4 are as defined in the description and claims, which are γ-secretase inhibitors and which may be useful in the treatment of Alzheimer's disease.
摘要翻译:本发明涉及式I的4-氧代-2,3,4,5-四氢 - 苯并[b] [1,4]二氮杂,其中R 1,R 2, R 3和R 4如说明书和权利要求中所定义,其是γ分泌酶抑制剂,其可用于治疗阿尔茨海默氏病。
摘要:
The invention relates to 4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepines of formula I wherein R1, R2, R3 and R4 are as defined in the description and claims, which are γ-secretase inhibitors and which may be useful in the treatment of Alzheimer's disease.
摘要翻译:本发明涉及式I的4-氧代-2,3,4,5-四氢 - 苯并[b] [1,4]二氮杂,其中R 1,R 2, R 3和R 4如说明书和权利要求中所定义,其是γ分泌酶抑制剂,其可用于治疗阿尔茨海默氏病。
摘要:
The invention relates to compounds of the formula I wherein R, R1, R2, R3, X, and n are defined in the specification. The invention also provides pharmaceutically suitable acid addition salts thereof and all forms of optically pure enantiomers, recemates or diastereomers and diastereomeric mixtures thereof. Compounds of the invention are useful for the treatment of Alzheimer's disease.